AbbVie | Amprion | Caughey | |
---|---|---|---|
Monomeric αSyn | 0.1 mg/ml recombinant human αSyn (w/o tag) | 0.3 mg/ml recombinant αSyn (C-term His) | 0.1 mg/ml recombinant K23Q αSyn (N-term His) |
CSF | 5% v/v | 20% v/v | 15% v/v |
Reaction volume | 100 μl | 200 μl | 100 μl |
Reaction duration | 70 h | 150 h | 48 h |
Reaction mixture | 100 mM NaH2PO4 (pH to 8.2 w/ NaOH) | 500 mM NaCl 100 mM PIPES (pH to 6.5 w/ NaOH) | 170 mM NaCl 40 mM NaH2PO4/ Na2HPO4 (pH to 8.0 w/ Na2HPO4) 0.0015% SDS |
Temperature | 33 °C | 37 °C | 42 °C |
Beads | 25 ± 3 mg of 0.10-mm zirconia/silica beads | Single 3/32-inch Si3N4 bead | 0.8-mm silica beads (6) |
Shaking protocol | 200 rpm shaking for 60 s and 14 min rest | 700 rpm shaking for 60 s every 30 min | 400 rpm shaking for 60 s every 60 s |
No. Replicates | 8 | 3 | 4 |
Threshold (RFU) | 3500 | Probabilistic algorithm based on assay kinetic parameters | 10% plate maximum fluorescence |
Positive | ≥ 50% positive replicates (4–8) | All 3 replicates positive by algorithm | > 25% replicates positive |
Negative | < 50% positive replicates (0–3) | 0–1 positive replicates | 0 positive replicates |
Inconclusive | n/a | 2 positive replicates | if 25% replicates positive, retested |